PLIANT THERAPEUTICS, INC. (PLRX)
Latest PLRX Insider Trades
- Keith Lamont Cummings - OfficerOpen-market sale$31K
Lily Cheung - OfficerOpen-market sale$10K- Bernard Coulie
About PLIANT THERAPEUTICS, INC. (PLRX)
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
- SOUTH SAN FRANCISCO, CA
- 49
- 2020
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 540,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
PLRX Insider Transactions (Form 4)
5822 Form 4 filings on record, the earliest from Jun 5, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert Iannone - Director | Grant or award | Stock Option (Right to Buy) | 60,000 |
Recent PLRX Form 8-K Filings
5PLRX Insider Trading - FAQ
What is the latest insider trade for PLRX?
PLIANT THERAPEUTICS, INC. (PLRX) had 8 insider filings in the last 90 days, with the most recent on 2026-07-13. The full record for PLRX runs to 22 Form 4 filings, the earliest from 2025-06-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PLRX stock?
No insider purchases of PLRX were filed in the last 90 days.
How many insiders are selling PLRX stock?
No insider sales of PLRX were filed in the last 90 days. 4 sales are on record for this company.
Where can I see PLRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks PLRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PLRX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add PLRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Robert Iannone view on EDGAR
- - Flavia Borellini view on EDGAR
- - Gayle A. Crowell view on EDGAR
- - Thomas A. McCourt view on EDGAR
- - Steve E. Krognes view on EDGAR
- - John T. Curnutte view on EDGAR
- - Hoyoung Huh view on EDGAR
- - Darren S. Cline view on EDGAR
- - Minnie Kuo view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where PLRX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track PLRX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
